Sanolla
Sanolla develops FDA-cleared AI-powered smart stethoscopes (VoqX) using patented infrasound technology to capture sub-30Hz body sounds, serving physicians, nurses, paramedics, and chronic disease patients with real-time on-device cardiac and pulmonary diagnostics.
- Company typePrivate
- Founded2016
- HeadquartersNesher, Israel
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Sanolla does
Sanolla is an Israeli medical device company founded in 2016 that develops infrasound-based AI diagnostic stethoscopes for healthcare providers and patients. The company is headquartered in Nesher, Israel with a US commercial office in Houston, Texas, and operates with 11-50 employees. Its platform centers on its patented BOOST™ infrasound technology, which captures low-frequency body sounds below the 30Hz threshold of human hearing and shifts them into the audible range, combined with on-device Edge AI algorithms trained on a proprietary database of over 100,000 auscultation recordings from clinical institutions across the EU and US.
The company's commercial product portfolio comprises two primary devices. VoqX is an FDA 510(k)-cleared smart stethoscope that performs full-spectrum auscultation for cardiac and pulmonary assessments, providing real-time AI classification for conditions including COPD, pneumonia, asthma, and cardiac morbidities in approximately 8 seconds per reading, with 40x sound amplification, active noise cancellation, Bluetooth connectivity, and a built-in display for waveforms and spectrographs. PyXy is a home-based monitoring device for chronic patients with congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD) that captures infrasound alongside ECG and SpO2 data for continuous remote monitoring and early deterioration detection. VoqX received FDA 510(k) clearance in April 2022 as the first stethoscope cleared to detect infrasound and audible information, and Sanolla holds ISO 13485 certification, Israeli Health Ministry approval, and HIPAA/GDPR-compliant data handling.
Sanolla generates revenue primarily through one-time hardware sales of VoqX at an introductory price of $499 (standard pricing $750) directly to physicians, nurses, paramedics, and healthcare providers via its own e-commerce storefront (sanolla.com/shop/), with an optional $32 extended warranty add-on and a 30-day money-back guarantee. The company also operates an enterprise inside-sales motion via a 'Get Your Special Quote' form for practice and bulk orders handled by product specialists. Distribution is anchored in the US with international shipping expanding to select countries. Sales were launched to the mass market via the Houston office in September 2025. Cumulative disclosed funding totals approximately $12.36M from sources including NextLeap Ventures ($5M seed, March 2016), the Israel Innovation Authority (~$1.9M in grants across 2017-2020), and the EU Horizon 2020 program (~$5.96M in October 2020 for COVID-19 related acoustic diagnostics).
Sanolla firmographics
Firmographics- Name
- Sanolla
- Legal name
- Sanolla Ltd.
- Website
- https://sanolla.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Sanolla develops FDA-cleared AI-powered smart stethoscopes (VoqX) using patented infrasound technology to capture sub-30Hz body sounds, serving physicians, nurses, paramedics, and chronic disease patients with real-time on-device cardiac and pulmonary diagnostics.
- Ownership category
- akta.pro rank
Sanolla industry classification
Industry- Product category
- Smart Medical Diagnostic Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
- akta.pro secondary industries
- Cardiology Telemedicine Platforms (HLALAGAB), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF)
Keywords
Where Sanolla is headquartered
LocationHeadquarters
- HQ city
- Nesher
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
Sanolla business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Others
Revenue model
- VoqX Smart Stethoscope Sales: One-time hardware sales of the VoqX FDA-cleared smart stethoscope. The device is sold directly to physicians, nurses, paramedics, and healthcare providers through the Sanolla website and sales team. Pricing is tiered with introductory pricing at $499 and standard pricing at $750.
- Extended Warranty: Sanolla offers extended warranty coverage purchasable at checkout for $32, extending the standard two-year warranty by one additional year to a total of three years.
- Home Monitoring Device (PyXy): The PyXy home-based monitoring device captures full-range body sounds including infrasound alongside ECG and SpO2 levels for chronic patients with CHF and COPD. This product line targets home monitoring for chronic disease management.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | VoqX introductory pricing - limited time offer |
| One time/ perpetual license | Pay-as-you-go | VoqX standard pricing |
| Unit Pricing | Pay-as-you-go | Extended warranty - one additional year |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
Sanolla product offering
Product offeringCore offering
Sanolla develops and sells AI-powered smart stethoscopes and home monitoring devices that capture full-spectrum body sounds including infrasound (below 30Hz) using its patented BOOST™ technology. The flagship VoqX is an FDA-cleared digital stethoscope with on-device Edge AI analysis for cardiac and pulmonary diagnostics, while the PyXy is a home monitoring device for chronic patients with CHF and COPD.
Product overview
Sanolla offers two AI-powered diagnostic devices: VoqX, an FDA-cleared smart stethoscope with infrasound auscultation and real-time AI analysis for heart and lung conditions targeting physicians, nurses, paramedics and home care providers; and PyXy, a home monitoring device for chronic patients (CHF/COPD) that captures infrasound, ECG and SpO₂ for continuous remote monitoring and early deterioration detection.
Differentiator
Problem solved
Functional benefit
Brands
- VoqX: AI-powered digital stethoscope capable of full-spectrum auscultation including infrasound detection, FDA-cleared for cardiac and pulmonary diagnostics.
- PyXy
- BOOST
Products and services
- VoqX Smart Stethoscope FDA-cleared AI-powered smart stethoscope capable of full-spectrum auscultation including infrasound detection (below 30Hz). Features real-time on-device Edge AI analysis for heart and lung conditions, built-in display for waveforms and spectrographs, 40x sound amplification, active noise cancellation, Bluetooth connectivity, and dual heart/lung modes. Sold to physicians, nurses, paramedics, and healthcare providers.
- VoqX Shop (Direct-to-Consumer Sales Channel) Direct-to-consumer sales page offering the VoqX stethoscope with introductory pricing at $499 (standard $750), carrying case, charging cable, instructions, free US shipping, and 30-day money-back guarantee for purchase by individual clinicians and consumers.
- PyXy Home Monitoring Device
Quantifiable outcome
- Pneumonia detection rates of 85-95% compared to 50-60% with traditional stethoscopes
- +2 more outcomes
Companies that use Sanolla
Customer profileNamed customers6 records
Segments7 records
Ideal customer profiles4 records
Sanolla technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature10 records
Sanolla partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered minor.
- RiesterminorListed as a partner on Sanolla's website. Nature of partnership not explicitly detailed in available source material.
- NataliminorListed as a partner on Sanolla's website. Nature of partnership not explicitly detailed in available source material.
- BeneVitminorListed as a partner on Sanolla's website. Nature of partnership not explicitly detailed in available source material.
- HelgelandssykehusetminorNorwegian hospital listed as a partner on Sanolla's website. Nature of partnership not explicitly detailed in available source material.
- Rambam Medical CenterminorIsraeli hospital listed as a partner on Sanolla's website, likely involved in clinical validation and research.
- Rabin Medical CenterminorIsraeli hospital (Clalit) listed as a partner on Sanolla's website.
- Carmel Medical CenterminorIsraeli hospital (Clalit) listed as a partner on Sanolla's website.
- Galilee Medical CenterminorIsraeli hospital where Dr. Mordechai Alpern serves as Senior Emergency Physician and provides VoqX testimonials.
- Emek Medical CenterminorIsraeli hospital (Clalit) listed as a partner on Sanolla's website.
- Hillel Yaffe Medical CenterminorIsraeli hospital listed as a partner on Sanolla's website.
- Barzilai Medical CenterminorIsraeli hospital listed as a partner on Sanolla's website.
- Shamir Medical CenterminorIsraeli hospital listed as a partner on Sanolla's website.
- Meir Medical CenterminorIsraeli hospital (Clalit) listed as a partner on Sanolla's website.
- Laniado HospitalminorIsraeli hospital listed as a partner on Sanolla's website.
- Tel Aviv Sourasky Medical CenterminorMajor Israeli hospital listed as a partner on Sanolla's website.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Sanolla competitors and assessment
Company assessmentDirect peers
- Eko Health: Eko Health is the leading AI-powered digital stethoscope company (Eko Core, DUO, SENSORA) and the most direct competitor to Sanolla's VoqX. Both firms sell AI-augmented auscultation devices to physicians and health systems and pursue similar pulmonology/cardiology diagnostic use cases.
- Thinklabs: Thinklabs manufactures digital stethoscopes (One, em) with amplification and digital signal capture aimed at clinicians seeking upgraded auscultation. It overlaps with VoqX on the digital-stethoscope-for-physicians product/market axis.
Broad incumbents
- 3M Littmann: 3M Littmann is the dominant incumbent in the stethoscope category and, through the Littmann CORE digital stethoscope (built with Eko), competes in the same AI auscultation space as VoqX. It shares Sanolla's physician customer base and offers overlapping digital auscultation features but as part of a broader medical disposables portfolio.
- AliveCor: AliveCor (KardiaMobile/Kardia devices) provides consumer and clinician ECG/EKG monitoring with AI interpretation, targeting similar cardiac diagnostic and remote-monitoring needs as VoqX and PyXy, though its modality is single-lead ECG rather than auscultation.
- iRhythm Technologies: iRhythm's Zio ambulatory cardiac monitor and AI ECG services address continuous cardiac arrhythmia detection for clinicians and patients. Its target indications and remote-monitoring business model closely overlap with PyXy's chronic-patient monitoring use case.
- Philips Healthcare: Philips offers broad patient monitoring and RPM solutions (telehealth, IntelliVue, remote cardiac/pulmonary programs) targeted at hospitals, IDNs, and chronic disease home monitoring. Its cardiac/pulmonary RPM portfolio overlaps with both VoqX in hospital settings and PyXy in home monitoring.
- Withings: Withings produces connected health devices (BPM Core, Body Cardio, ScanWatch with ECG) for consumers and clinicians. Its cardio-monitoring devices overlap with VoqX and PyXy across consumer/clinical ECG, BPM, and home monitoring applications.
Emerging players
- Sonavi Labs: Sonavi Labs develops AI-enabled digital stethoscopes for respiratory disease detection (notably tuberculosis), pairing acoustic capture with machine-learning classification. It is an emerging peer with technology and use case closely comparable to Sanolla's VoqX but with a narrower indication focus.
- HD Medical: HD Medical builds AI-augmented auscultation and stethoscope products (e.g., HD Steth) for cardiac and pulmonary screening. Its product offering and clinical-decision-support positioning closely parallel Sanolla's VoqX for clinicians and point-of-care screening.
Others
- Caretaker Medical: Caretaker Medical provides wearable, wireless continuous vital-sign monitors capturing blood pressure and heart rate using pulse-deconvolution technology, sold to clinicians for remote patient monitoring. It is an enabling/adjacent peer whose RPM infrastructure and clinician relationships could overlap with PyXy's chronic-monitoring channel.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks7 records
Key highlights7 records
Customer concentration
Sanolla social profiles
Digital presenceSanolla compliance and trust
Trust signalCompliance4 records
Sanolla financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sanolla leadership team
Management profileNumber of profiles
Profiles9 records
Sanolla funding detail
Funding detailFunding overview
Funding rounds6 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sanolla M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sanolla
What does Sanolla do?
Sanolla develops and sells AI-powered smart stethoscopes and home monitoring devices that capture full-spectrum body sounds including infrasound (below 30Hz) using its patented BOOST™ technology. The flagship VoqX is an FDA-cleared digital stethoscope with on-device Edge AI analysis for cardiac and pulmonary diagnostics, while the PyXy is a home monitoring device for chronic patients with CHF and COPD.
Is Sanolla a public or private company?
Sanolla is a private company. It is classified as venture growth investor backed and is currently operating.
When was Sanolla founded?
Sanolla was founded in 2016. It employs 11 to 50 people.
Where is Sanolla based?
Sanolla is headquartered in Nesher, Israel, in the Middle East region.
How does Sanolla make money?
Three revenue lines are on record. VoqX Smart Stethoscope Sales are the primary driver. The others are extended Warranty and home Monitoring Device (PyXy).
Who are Sanolla's main competitors?
Direct peers on record are Eko Health and Thinklabs. Broad incumbents are 3M Littmann, AliveCor, iRhythm Technologies, Philips Healthcare and Withings. Emerging players are Sonavi Labs and HD Medical. Caretaker Medical is listed as an others.
Does Sanolla have an API?
No public API is recorded for Sanolla.
What industry is Sanolla in?
Sanolla's product category is Smart Medical Diagnostic Devices. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLALAGAB, Cardiology Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3845.